BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 25975511)

  • 1. Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008-2013.
    Nabarro LE; Lever RA; Armstrong M; Chiodini PL
    Clin Microbiol Infect; 2015 Aug; 21(8):791-6. PubMed ID: 25975511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitroimidazole-refractory giardiasis: a growing problem requiring rational solutions.
    Carter ER; Nabarro LE; Hedley L; Chiodini PL
    Clin Microbiol Infect; 2018 Jan; 24(1):37-42. PubMed ID: 28624613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Nitroimidazole refractory giardiasis is common in Matanzas, Cuba and effectively treated by secnidazole plus high-dose mebendazole or quinacrine: a prospective observational cohort study.
    Cañete R; Noda AL; Rodríguez M; Brito K; Herrera E; Kofoed PE; Ursing J
    Clin Microbiol Infect; 2020 Aug; 26(8):1092.e1-1092.e6. PubMed ID: 31901492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment strategies for nitroimidazole-refractory giardiasis: a systematic review.
    Bourque DL; Neumayr A; Libman M; Chen LH
    J Travel Med; 2022 Jan; 29(1):. PubMed ID: 34350966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Use of Quinacrine in Nitroimidazole-resistant Giardia Duodenalis: An Old Drug for an Emerging Problem.
    Requena-Méndez A; Goñi P; Rubio E; Pou D; Fumadó V; Lóbez S; Aldasoro E; Cabezos J; Valls ME; Treviño B; Martínez Montseny AF; Clavel A; Gascon J; Muñoz J
    J Infect Dis; 2017 Mar; 215(6):946-953. PubMed ID: 28453841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Tolerability of Quinacrine Monotherapy and Albendazole Plus Chloroquine Combination Therapy in Nitroimidazole-Refractory Giardiasis: A TropNet Study.
    Neumayr A; Schunk M; Theunissen C; Van Esbroeck M; Mechain M; Hatz C; Mørch K; Soriano Pérez MJ; Sydow V; Sothmann P; Kuenzli E; Rothe C; Bottieau E
    Clin Infect Dis; 2021 Oct; 73(8):1517-1523. PubMed ID: 34115100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome.
    Abboud P; Lemée V; Gargala G; Brasseur P; Ballet JJ; Borsa-Lebas F; Caron F; Favennec L
    Clin Infect Dis; 2001 Jun; 32(12):1792-4. PubMed ID: 11360222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Giardiasis treatment: an update with a focus on refractory disease.
    Mørch K; Hanevik K
    Curr Opin Infect Dis; 2020 Oct; 33(5):355-364. PubMed ID: 32773501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giardiasis: report of a case refractory to treatment.
    Iza JA; Iza SN; Olivera MJ
    Infez Med; 2019 Sep; 27(3):336-339. PubMed ID: 31545780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refractory giardiasis in Spanish travellers.
    Muñoz Gutiérrez J; Aldasoro E; Requena A; Comin AM; Pinazo MJ; Bardají A; Oliveira I; Valls ME; Gascon J
    Travel Med Infect Dis; 2013; 11(2):126-9. PubMed ID: 23218784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of patients with refractory giardiasis.
    Nash TE; Ohl CA; Thomas E; Subramanian G; Keiser P; Moore TA
    Clin Infect Dis; 2001 Jul; 33(1):22-8. PubMed ID: 11389490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinacrine Treatment of Nitroimidazole-Refractory Giardiasis.
    Ydsten KA; Hellgren U; Asgeirsson H
    J Infect Dis; 2022 May; 225(10):1773-1776. PubMed ID: 34036328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for and management of metronidazole-refractory giardiasis in international travellers: A retrospective analysis.
    Peters TE; Kreuels B; Addo MM; Tannich E; Rothe C
    Travel Med Infect Dis; 2021; 43():102090. PubMed ID: 34082086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of giardiasis after nonresponse to nitroimidazole.
    Meltzer E; Lachish T; Schwartz E
    Emerg Infect Dis; 2014 Oct; 20(10):1742-4. PubMed ID: 25271363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractory giardiasis: a molecular appraisal from a tertiary care centre in India.
    Yadav P; Tak V; Mirdha BR; Makharia GK
    Indian J Med Microbiol; 2014; 32(4):378-82. PubMed ID: 25297020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Giardiasis: a pharmacotherapy review.
    Escobedo AA; Cimerman S
    Expert Opin Pharmacother; 2007 Aug; 8(12):1885-902. PubMed ID: 17696791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A family cluster of giardiasis with variable treatment responses: refractory giardiasis in a family after a trip to India.
    Requena-Méndez A; Goñi P; Lóbez S; Oliveira I; Aldasoro E; Valls ME; Clavel A; Gascón J; Muñoz J
    Clin Microbiol Infect; 2014 Feb; 20(2):O135-8. PubMed ID: 23926944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of refractory paediatric giardiasis using secnidazole plus albendazole: a case series.
    Escobedo AA; Almirall P; Chirino E; Pacheco F; Duque A; Avila I
    Infez Med; 2018 Dec; 26(4):379-384. PubMed ID: 30555145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined oral and endoscopic mepacrine therapy in therapy-resistant symptomatic giardiasis].
    Rowedder A; Meier R; Wegmann W; Gyr K
    Schweiz Med Wochenschr; 1991 Sep; 121(38):1383-6. PubMed ID: 1925468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of chronic Giardia infection.
    Escobedo AA; Hanevik K; Almirall P; Cimerman S; Alfonso M
    Expert Rev Anti Infect Ther; 2014 Sep; 12(9):1143-57. PubMed ID: 25059638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.